JayGlennWohlgemuthMD

PubMed

• 1 citations
  Trpv1 and Trpa1 are not essential for Psickle-like activity in red cells of the SAD mouse model of sickle cell disease
  David H. Vandorpe, Alicia Rivera, Boris E. Shmukler, Jay Wohlgemuth, Jeffrey S. Dlott, L. Michael Snyder, Marie Trudel, Carlo Brugnara, Seth L. Alper> ;Blood Cells, Molecules & Diseases. 2021 Oct 29
• 88 citations
  Viral dynamics of acute SARS-CoV-2 infection and applications to diagnostic and public health strategies.
  Stephen M Kissler, Joseph R. Fauver, Christina D. Mack, Scott W. Olesen, Caroline G. Tai, Kristin Y. Shiue, Chaney C. Kalinich, Sarah Jednak, Isabel M. Ott, Chantal B....> ;Plos Biology. 2021 Jul 12
• 5 citations
  A Grammastola spatulata mechanotoxin-4 (GsMTx4)-sensitive cation channel mediates increased cation permeability in human hereditary spherocytosis of multiple genetic e...
  David H. Vandorpe, Boris E. Shmukler, Yann Ilboudo, Swati S. Bhasin, Beena E Thomas, Alicia Rivera, Jay Wohlgemuth, Jeffrey S. Dlott, L. Michael Snyder, Colin A. Sieff...> ;Haematologica. 2021 Jun 10
• 12 citations
  Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease.
  Franklin R Cockerill, Jay Wohlgemuth, Jeff Radcliff, Christine E Sabol, Hema Kapoor, Jeffrey S. Dlott, Elizabeth M. Marlowe, Nigel J. Clarke> ;Population Health Management. 2021 Feb 1
• 12 citations
  Insights from Patterns of SARS-CoV-2 Immunoglobulin G Serology Test Results from a National Clinical Laboratory, United States, March-July 2020.
  Harvey W. Kaufman, Zhen Chen, William A. Meyer, Jay Wohlgemuth> ;Population Health Management. 2021 Feb 5
• 10 citations
  One-Year Effects of Omega-3 Treatment on Fatty Acids, Oxylipins, and Related Bioactive Lipids and Their Associations with Clinical Lipid and Inflammatory Biomarkers: F...
  Olga Demler, Yanyan Liu, Heike Luttmann-Gibson, Jeramie D. Watrous, Kim A. Lagerborg, Hesam Dashti, Franco Giulianini, Mallory Heath, Carlos A. Camargo, William S. Har...> ;Metabolites. 2020 Oct 27
• A Simple Algorithm for Return to Workplace Employer Antibody Testing.
  William H. Shrank, Brian Caveney, Steve Miller, Rhonda M. Medows, Alejandro C. Arroliga, Benjamin Doga, Kevin Ban, Sean Muldoon, J. Michael Seiden, Ian Tong, Sreekanth...> ;Population Health Management. 2020 Oct 5
• 5 citations
  Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia.
  Boris E. Shmukler, Alicia Rivera, Parul Bhargava, Katherine Nishimura, Edward H. Kim, Ann Hsu, Jay Wohlgemuth, James Morton, L. Michael Snyder, Lucia De Franceschi, Ma...> ;Blood Cells, Molecules & Diseases. 2020 Mar 1
• 13 citations
  Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.
  Zareen Farukhi, Olga Demler, Michael P. Caulfield, Krishnaji R. Kulkarni, Jay Wohlgemuth, Michael Cobble, Heike Luttmann-Gibson, Chunying Li, John R Nelson, Nancy R. C...> ;Journal of Clinical Lipidology. 2020 Feb 21
• 4 citations
  Self-Insured Employer Health Benefits Strategy Established a Negative Cost Trend While Improving Performance.
  Steven E Goldberg, Maren S. Fragala, Jay Wohlgemuth> ;Population Health Management. 2019 Dec 2
• 36 citations
  Dementia assessment and management in primary care settings: a survey of current provider practices in the United States
  Alissa Bernstein, Kirsten M. Rogers, Katherine L. Possin, Natasha Z.R. Steele, Christine S. Ritchie, Joel H. Kramer, Michael D. Geschwind, Joseph Higgins, Jay Wohlgemu...> ;BMC Health Services Research. 2019 Nov 29
• 18 citations
  Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vita...
  Heike Luttmann-Gibson, Samia Mora, Carlos A. Camargo, Nancy R. Cook, Olga Demler, Amit Ghoshal, Jay Wohlgemuth, Kris Kulkarni, Julia A Larsen, James Prentice, Michael ...> ;Contemporary Clinical Trials. 2019 Oct 24
• 7 citations
  Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+ hereditary xerocytosis red cells.
  Alicia Rivera, David H. Vandorpe, Boris E. Shmukler, Immacolata Andolfo, Achille Iolascon, Natasha M. Archer, Estela Shabani, Michael Auerbach, Nelson Hamerschlak, Jam...> ;American Journal of Physiology. Cell Physiology. 2019 Aug 1
• 20 citations
  Validation of a genetic risk score for atrial fibrillation: A prospective multicenter cohort study.
  Evan D. Muse, Nathan E. Wineinger, Emily Spencer, Melissa Peters, Riley Henderson, Yunyue Zhang, Paddy M. Barrett, Steven P. Rivera, Jay Wohlgemuth, James J. Devlin, D...> ;Plos Medicine. 2018 Mar 13
• 83 citations
  Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justif...
  Samia Mora, Michael P. Caulfield, Jay Wohlgemuth, Zhihong Chen, H.Robert Superko, Charles M. Rowland, Robert J. Glynn, Paul M. Ridker, Ronald M. Krauss> ;Circulation. 2015 Dec 8
• 10 citations
  Response to Letter Regarding Article, “Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk: An Analysis From the JUPITER Trial (Justificati...
  Amit Khera, Brendan M. Everett, Michael P. Caulfield, Feras M. Hantash, Jay Wohlgemuth, Paul M. Ridker, Samia Mora> ;Circulation. 2014 Oct 21
• 282 citations
  Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: An analysis from the JUPITER trial (justification for the use of statins in prevention...
  Amit Khera, Brendan M. Everett, Michael P. Caulfield, Feras M. Hantash, Jay Wohlgemuth, Paul M. Ridker, Samia Mora> ;Circulation. 2014 Feb 11
• 11 citations
  Cardiovascular Pharmacogenomics: Current Status and Future Directions—Report of a National Heart, Lung, and Blood Institute Working Group
  Kiran Musunuru, Dan M. Roden, Robin Boineau, Michael R. Bristow, Timothy A. McCaffrey, Christopher Newton-Cheh, Dina N. Paltoo, Yves Rosenberg, Jay Wohlgemuth, Issam Z...> ;Journal of the American Heart Association. 2012 Apr 24
• 17 citations
  Multiplex ligation-dependent probe amplification for detection of chromosomal abnormalities in myelodysplastic syndrome and acute myeloid leukemia
  Amber C. Donahue, Adam Abdool, Renu Gaur, Jay Wohlgemuth, Chen-Hsiung Yeh> ;Leukemia Research. 2011 Nov 1
• Charting a path for Plavix response testing.
  Jay Wohlgemuth> ;MLO. 2011 Apr 1
• 24 citations
  Detection, analysis and clinical validation of chromosomal aberrations by multiplex ligation-dependent probe amplification in chronic leukemia.
  Adam Abdool, Amber C. Donahue, Jay Wohlgemuth, Chen-Hsiung Yeh> ;Plos One. 2010 Oct 25
• 29 citations
  Gene Expression Profiling Distinguishes a Molecular Signature for Grade 1B Mild Acute Cellular Rejection in Cardiac Allograft Recipients
  Daniel Bernstein, Gavin E. Williams, Howard J. Eisen, Seema Mital, Jay Wohlgemuth, Tod M. Klingler, Kenneth C. Fang, Mario C. Deng, Jon A. Kobashigawa> ;The Journal of Heart and Lung Transplantation. 2007 Dec 1
• 17 citations
  Distinct inflammatory gene pathways induced by particles
  Andrew D. Pearle, Mary K. Crow, Diptendu S Rakshit, Jay Wohlgemuth, Bryan J. Nestor> ;Clinical Orthopaedics and Related Research. 2007 May 1
• 49 citations
  Gene expression profiles and B-type natriuretic peptide elevation in heart transplantation: more than a hemodynamic marker.
  Mandeep R. Mehra, Patricia A. Uber, Dirk Walther, Mark R. Vesely, Jay Wohlgemuth, James Prentice, Darren Tayama, Margaret E. Billingham> ;Circulation. 2006 Jul 4
• 102 citations
  Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients.
  Charles C. Marboe, Margaret E. Billingham, Howard J. Eisen, Mario C. Deng, Helen M. Baron, Mandeep R. Mehra, Sharon A. Hunt, Jay Wohlgemuth, Irfan Mahmood, James Prent...> ;The Journal of Heart and Lung Transplantation. 2005 Jul 1
• Join now to see all